160 Series B healthtech investors
We list 160 Series B healthtech investors as of November 2026: 69 have an SEC filing on file and 91 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (22), New York (10) and Massachusetts (7).
Top 5 Series B healthtech investors, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series B is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Innovation Industries
Type: VC firm · HQ: Amsterdam, Netherlands · Stages: Series A, Series B, Growth · Focus: Healthtech, Deep Tech, AI, Food and Beverage · Latest activity: New fund, Oct 2026 · Fund size or assets: €1.0B (own site)
Latest fund filing dated Oct 2026; €1.0B on file (own site); states healthtech and digital health as a focus; backs Series A, Series B, growth-stage; 4 named decision-makers on file.
Claret Capital Partners
Type: Venture debt · HQ: London, United Kingdom · Stages: Series B, Growth, Late stage · Focus: Healthtech, Biotech, Climate Tech, SaaS · Latest activity: New deal, Oct 2026 · Fund size or assets: €575M (own site)
Dated new deal in Oct 2026; €575M on file (own site); states healthtech and digital health as a focus; backs Series B, growth-stage, late stage; 8 named decision-makers on file.
Alpha Partners
Type: VC firm · HQ: New York, NY · Stages: Series B, Growth · Focus: Healthtech, AI, Developer Tools, Cybersecurity · Latest activity: New fund, Oct 2026 · Fund size on file: $200M (SEC Form D, 2024)
Latest fund filing dated Oct 2026; $200M fund on file (SEC Form D, 2024); states healthtech and digital health as a focus; backs Series B, growth-stage; 8 named decision-makers on file.
BGF
Type: VC firm · HQ: United Kingdom · Stages: Seed, Series A, Series B, Growth · Focus: Healthtech, Edtech, Developer Tools, Mobility · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: £3.0B (own site)
Portfolio news dated Oct 2026; £3.0B on file (own site); states healthtech and digital health as a focus; backs seed, Series A, Series B; 8 named decision-makers on file.
Cathay Innovation
Type: VC firm · HQ: Paris, France · Stages: Seed, Series A, Series B, Growth, Late stage · Focus: Healthtech, AI, Robotics, Fintech · Latest activity: Portfolio news, Aug 2026 · Fund size or assets: €2.5B (own site)
Portfolio news dated Aug 2026; €2.5B on file (own site); states healthtech and digital health as a focus; backs seed, Series A, Series B; 5 named decision-makers on file.
First 25 of 160 Series B healthtech investors
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Innovation Industries | VC firm | Amsterdam, Netherlands | Series A, Series B, Growth | Healthtech, Deep Tech, AI, Food and Beverage | New fund, Oct 2026 | €1.0B (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Healthtech, Biotech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Alpha Partners | VC firm | New York, NY | Series B, Growth | Healthtech, AI, Developer Tools, Cybersecurity | New fund, Oct 2026 | $200M (SEC Form D, 2024) | 4 Nov 2026 | 8 names, firm email · Unlock |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Healthtech, Edtech, Developer Tools, Mobility | Portfolio news, Oct 2026 | £3.0B (own site) | 4 Nov 2026 | 8 names · Unlock |
| Cathay Innovation | VC firm | Paris, France | Seed, Series A, Series B, Growth, Late stage | Healthtech, AI, Robotics, Fintech | Portfolio news, Aug 2026 | €2.5B (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| Greycroft | VC firm | New York, NY | Series A, Series B, Growth | Healthtech, AI, Industrial Tech, Defense Tech | New deal, Oct 2026 | $600M (SEC Form D, 2022) | 4 Nov 2026 | 5 names · Unlock |
| Balderton Capital | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Developer Tools | Portfolio news, Oct 2026 | $5.7B (own site) | 4 Nov 2026 | 8 names · Unlock |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Healthtech, Biotech, Medtech | Portfolio news, Oct 2026 | $2.8B (own site) | 7 Nov 2026 | 1 name, firm email · Unlock |
| True Beauty Ventures | VC firm | Palm Beach Gardens, FL | Seed, Series A, Series B | Healthtech, Consumer, CPG | New fund, Oct 2026 | $308M (SEC Form D, 2022) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Parkwalk Advisors | SEIS/EIS fund | London, United Kingdom | Seed, Series A, Series B, Growth | Healthtech, AI, Industrial Tech, Energy | New fund, Sep 2026 | £500M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Healthtech, Biotech, Medtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 7 Nov 2026 | No contact on file |
| OneTarget | VC firm | Berlin, Germany | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Consumer | Portfolio news, Sep 2026 | $3.0B (own site) | 4 Nov 2026 | firm email · Unlock |
| Kibo Ventures | VC firm | Spain | Seed, Series A, Series B | Healthtech, Generalist, SaaS, Cybersecurity | New fund, Oct 2026 | €500M (own site) | 7 Nov 2026 | 5 names · Unlock |
| Menlo Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Series B, Growth | Healthtech, AI, Media, Robotics | New fund, Sep 2026 | $800M (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
| Translink Capital | VC firm | Palo Alto, CA | Seed, Series A, Series B | Healthtech, AI, Developer Tools, Mobility | New fund, Sep 2026 | $174M (SEC Form D, 2021) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Capricorn Partners | VC firm | Leuven, Belgium | Seed, Series A, Series B, Growth | Healthtech, Deep Tech, Climate Tech, SaaS | Portfolio news, Oct 2026 | €300M (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| Bison Ventures | VC firm | San Francisco, CA | Pre-seed, Seed, Series A, Series B | Healthtech, AI, Energy, Biotech | New fund, Oct 2026 | $160M (SEC Form D, 2025) | 4 Nov 2026 | 2 names, firm email · Unlock |
| Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Healthtech, Biotech, Medtech | New deal, Sep 2026 | €230M (own site) | 7 Nov 2026 | 3 names, firm email · Unlock |
| IVP: Venture capital for the Exceptional | VC firm | Menlo Park, CA | Series B, Growth | Healthtech, AI, Developer Tools, SaaS | New fund, Oct 2026 | $60M (SEC Form D, 2026) | 4 Nov 2026 | 8 names · Unlock |
| Sandbox Clinical Ventures | VC firm | Chicago, IL | Seed, Series A, Series B, Growth | Healthtech, Insurtech, AI, Fintech | New fund, Sep 2026 | $100M (SEC Form D, 2021) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Cultivation Capital | VC firm | St. Louis, MO | Seed, Series A, Series B | Healthtech, Biotech, SaaS, Agritech | New fund, Sep 2026 | $100M (SEC Form D, 2022) | 4 Nov 2026 | 8 names · Unlock |
| Overlap Holdings | VC firm | Hicksville, NY | Seed, Series A, Series B | Healthtech, AI, Energy, Climate Tech | New fund, Oct 2026 | $16M (SEC Form D, 2023) | 4 Nov 2026 | 8 names · Unlock |
| Claritas Signal Partners | VC firm | Nashville, TN | Seed, Series A, Series B, Growth | Healthtech, AI, Media, Developer Tools | New deal, Aug 2026 | $14M (SEC Form D, 2021) | 5 Nov 2026 | 8 names · Unlock |
| How Women Invest | VC firm | Oakland, CA | Pre-seed, Seed, Series A, Series B | Healthtech, AI, B2B, Climate Tech | New fund, Sep 2026 | $12M (SEC Form D, 2026) | 4 Nov 2026 | 8 names · Unlock |
| Lightspeed Venture Partners | VC firm | Menlo Park, CA | Seed, Series A, Series B, Growth | Healthtech, AI, Gaming, SaaS | New fund, Jul 2026 | $1.2B (SEC Form D, 2024) | 4 Nov 2026 | 8 names · Unlock |
You are seeing 25 of 160. The full list adds 135 more investors and 823 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 160 break down
By region
| Region | On this list | Share |
|---|---|---|
| United States | 69 | 43% |
| United Kingdom | 32 | 20% |
| Europe | 59 | 37% |
By US state
| US state | On this list | Share |
|---|---|---|
| California | 22 | 14% |
| New York | 10 | 6% |
| Massachusetts | 7 | 4% |
| Florida | 3 | 2% |
| Tennessee | 3 | 2% |
| New Jersey | 3 | 2% |
| Texas | 3 | 2% |
| Illinois | 2 | 1% |
| Michigan | 2 | 1% |
| Washington | 2 | 1% |
By European country
| European country | On this list | Share |
|---|---|---|
| France | 21 | 13% |
| Germany | 8 | 5% |
| Netherlands | 5 | 3% |
| Belgium | 5 | 3% |
| Switzerland | 3 | 2% |
| Spain | 3 | 2% |
| Norway | 3 | 2% |
| Italy | 3 | 2% |
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 133 | 83% |
| Corporate VC | 11 | 7% |
| Fund manager | 6 | 4% |
| Government or university fund | 4 | 2% |
| Venture debt | 2 | 1% |
| SEIS/EIS fund | 2 | 1% |
Method and limits
- Source
- 69 of the 160 rows carry an SEC filing (Form D or Form ADV). All 160 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at Series B.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series B is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 9 Nov 2026.
- Fill rates
- Of 160 rows: stage 160, sector 160, fund size 101, website 160. In the paid file: named decision-makers on 147 rows, firm email on 86, LinkedIn page on 114, check size on 39.
- Corrections
- Email [email protected] or use the update form. We act within 5 working days.
Questions
How many Series B healthtech investors are there?
We list 160 as of November 2026. 80 of the 160 have a fund filing or a dated deal in the last 12 months.
Which Series B healthtech investors raised a new fund in the last 12 months?
30 of the 160 have a fund filing dated in the last 12 months. The most recent on this list are IVP: Venture capital for the Exceptional (Oct 2026), True Beauty Ventures (Oct 2026) and Bison Ventures (Oct 2026).
What is the typical fund size of Series B healthtech investors?
The median fund size on file for this list is $87M, across the 48 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 112 do not disclose a size there.
How do I contact Series B healthtech investors?
The paid file holds 823 named decision-makers across 147 of these 160 and a firm email for 86. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on Series B healthtech investors come from?
69 of the 160 rows have an SEC filing on file (Form D or Form ADV) and 91 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.
Broader lists
Narrower lists
Related lists
Seed healthtech investors (800)Pre-seed healthtech investors (408)Series A healthtech investors (401)Growth-stage healthtech investors (316)Series B AI investors (204)Series B SaaS investors (196)Series B fintech investors (127)Series B deep tech investors (113)Series B climate tech investors (98)Series B biotech investors (73)Series B cybersecurity investors (65)Series B consumer investors (59)Series B medtech investors (57)Series B energy investors (55)Series B B2B investors (46)Series B industrial tech investors (40)Series B mobility investors (39)Series B hardware investors (34)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to healthtech and digital health and Series B. Guide: how to find investors for a healthtech and digital health startup. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.